Frank-Raue Karin, Rondot Susanne, Hoeppner Wolfgang, Goretzki Peter, Raue Friedhelm, Meng Wieland
J Clin Endocrinol Metab. 2005 Jul;90(7):4063-7. doi: 10.1210/jc.2004-1759. Epub 2005 May 3.
Primary hyperparathyroidism (HPT) presents as a part of inherited syndromes such as multiple endocrine neoplasia (MEN) types 1 and 2. In patients with MEN1, parathyroid hyperplasia or multiple adenomas occur in approximately 90-95%. MEN2A-related HPT is characterized by a mild hypercalcemia, which is mostly asymptomatic.
Here we present a family with coexistence of MEN1 gene mutation and RET mutation.
Six family members carrying MEN1 gene mutation IVS5 + 1G>A only, one family member with RET mutation Y791F, and three family members with both MEN1 gene and RET mutation were studied. The key to diagnosis was recurrent HPT in a young male carrying RET mutation Y791F, a mutation not likely to give rise to recurrent HPT.
MEN1 gene mutation and RET codon 791 mutation in the same patient did not affect the typical phenotype of MEN1 or MEN2, and also the course of diseases seems to be unchanged. The reason may be that both mutations, although contributing to tumor pathogenesis, do not interact and induce a worsening of the cancer syndromes.
原发性甲状旁腺功能亢进症(HPT)是遗传性综合征的一部分,如多发性内分泌腺瘤病(MEN)1型和2型。在MEN1患者中,甲状旁腺增生或多发性腺瘤的发生率约为90 - 95%。与MEN2A相关的HPT的特征是轻度高钙血症,大多无症状。
本文介绍一个同时存在MEN1基因突变和RET基因突变的家系。
对仅携带MEN1基因突变IVS5 + 1G>A的6名家庭成员、携带RET基因突变Y791F的1名家庭成员以及同时携带MEN1基因和RET基因突变的3名家庭成员进行了研究。诊断的关键在于一名携带RET基因突变Y791F的年轻男性反复发生HPT,而该突变不太可能导致反复发生HPT。
同一患者中MEN1基因突变和RET密码子791突变并未影响MEN1或MEN2的典型表型,疾病进程似乎也未改变。原因可能是这两种突变虽然都参与肿瘤发病机制,但并不相互作用并导致癌症综合征恶化。